Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
Tickers AAPL ABBV AMD AMZN
Tags SNY SBUX GOOG
From Benzinga
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
Tickers NEWS REGN SNY
Tags General FDA News
From Benzinga
French Drugmaker Sanofi Agrees To Buy Inhibrx's Candidate For Rare Genetic Indication, For About $2.2B
Tickers INBX NEWS SNY
Tags INBX Market News News
From Benzinga
Olympic Sponsor Sanofi Makes Major Play In Rare Disease Arena $2.2 Billion Acquisition Of Inhibrx Project
Tickers INBX NEWS SNY
Tags News INBX Inhibrx
From Benzinga
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
Tickers ACRS NEWS REGN SNY
Tags REGN Benzinga Biotech
From Benzinga
Sanofi's Olympic Endeavor: Leap Into Olympic Sponsorship Signals Cultural Transformation
Tickers CRERF CRRFY LVMHF LVMUY
Tags AI Generated LVMHF Market News
From Benzinga
China Approves AstraZeneca-Sanofi's Respiratory Syncytial Virus Drug To Prevent Infection In Infants
Tickers AZN NEWS SNY
Tags Health Care Market News AZN
From Benzinga
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
Tickers GSK NEWS PFE SNY
Tags TAK Health Care SNY
From Benzinga
Why First Wave BioPharma Shares Are Skyrocketing Today
Tickers FWBI NEWS SNY
Tags SNY Briefs Benzinga
From Benzinga
Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?
Tickers JNJ MGTX SNY
Tags General why it's moving Market News
From Benzinga
European Drugmaker Sanofi Ends Tusamitamab Ravtansine Lung Cancer Program After Disappointing Data
Tickers SNY
Tags Large Cap General Benzinga
From Benzinga
Looking Into Sanofi's Recent Short Interest
Tickers SNY
Tags Market News Short Ideas Trading Ideas
From Benzinga
First Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused Pipeline
Tickers FWBI SNY
Tags Market News News FWBI
From Benzinga
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
Tickers ARCT CPRX HRMY MGNX
Tags PFE Market News CPRX
From InvestorPlace
It's Almost 2024: 3 Top Stocks to Buy Before the New Year
Tickers AMZN GOOG GOOGL KO
Tags Recent Press Releases REGN KO
From Motley Fool
French Drugmaker Sanofi Secures European Medicines Agency's Positive Opinion For Sleeping Sickness Treatment
Tickers SNY
Tags SNY Briefs Biotech
From Benzinga
3 Stocks to Buy Before 2024 That Can Set You Up For Life
Tickers CCL GOOG GOOGL REGN
Tags Market News GOOGL CCL
From Motley Fool
French Pharma Giant Sanofi Drops Rare Disease Drug Pact As Federal Trade Commission Puts Antitrust Obstacle
Tickers SNY
Tags General Government Equities
From Benzinga
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
Tickers JNJ SNY VNDA
Tags JNJ VNDA Market News
From Benzinga
Sanofi Lays Out Ambitious Plans To Bolster Its Pipeline, Highlights 12 Blockbuster Opportunities
Tickers SNY
Tags News Health Care Market News
From Benzinga
IGM Biosciences Increases Focus On Autoimmune Diseases, Stops All Blood Cancer-Related Studies
Tickers IGMS SNY
Tags Biotech Briefs SNY
From Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
Tickers MKGAF MKKGY SNY
Tags Health Care Biotech Briefs
From Benzinga
Investor Demand for Clarity Grows Amid Sanofi's Strategic R&D Shift
Tickers SNY
Tags General Expert Ideas News
From Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
Tickers AZN LLY NVO SNY
Tags General Markets Market News
From Benzinga
How Is The Market Feeling About Sanofi?
Tickers SNY
Tags BZI/SHORTHIST Short Sellers SNY
From Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Tickers GILD SNY
Tags GILD SNY Recent Press Releases
From Motley Fool
Sanofi/Regeneron's Blockbuster Prescription Drug Dupixent Shows Additional Promise In Chronic Lung Disorder
Tickers REGN SNY
Tags News Market News Markets
From Benzinga
Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst
Tickers ARGX DNTH SNY
Tags General Analyst Ratings DNTH
From Benzinga
US CDC Rolls Out Additional Doses For Sanofi/AstraZeneca Recently Approved Respiratory Infection Drug As Demand Surges
Tickers AZN SNY
Tags Market News News Media
From Benzinga
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
Tickers GSK HLN JNJ KVUE
Tags KVUE General Rumors
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.